Refine Your Results

Click below to filter your search results

Search Results

Return to List
Results 81–100 of 217
Title Date
81.

Improving Medication Safety

Number 531

(Replaces No. 331, April 2006 and No. 400, March 2008)

ABSTRACT: Despite significant national attention, medical errors continue to pervade the U.S. health care system. Medication-related errors consistently rank at the top of all medical errors, which account for thousands of preventable deaths annually in the United States. There are a variety of me...

August 2012

PDF Format
82.

Inappropriate Reimbursement Practices by Third-Party Payers

Number 250

The American College of Obstetricians and Gynecologists (ACOG) Committee on Coding and Nomenclature believes that physicians must code accurately the services they provide and the diagnoses that justify those services for purposes of appropriate payment. This requirement is consistent with the rul...

January 2001

PDF Format
83.

Increasing Access to Abortion

Number 613

(Replaces No. 424, January 2009)

ABSTRACT: Safe, legal abortion is a necessary component of women’s health care. The American College of Obstetricians and Gynecologists supports the availability of high-quality reproductive health services for all women and is committed to improving access to abortion. Access to abortion is threa...

November 2014

PDF Format
84.

Increasing Use of Contraceptive Implants and Intrauterine Devices To Reduce Unintended Pregnancy

Number 450

(Reaffirmed 2011)

ABSTRACT: High unintended pregnancy rates in the United States may in part be the result of relatively low use of long-acting reversible contraceptive (LARC) methods, specifically the contraceptive implant and intrauterine devices. Top-tier reversible methods share the characteristic of requiring ...

December 2009

PDF Format
85.

Induced Abortion and Breast Cancer Risk

Number 434

(Reaffirmed 2013, Replaces No. 285, August 2003)

ABSTRACT: The relationship between induced abortion and the subsequent development of breast cancer has been the subject of a substantial amount of epidemiologic study. Early studies of the relationship between prior induced abortion and breast cancer risk were methodologically flawed. More rigoro...

June 2009

PDF Format
86.

Influenza Vaccination During Pregnancy

Number 608

(Replaces No. 468, October 2010)

ABSTRACT: The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend that all adults receive an annual influenza vaccine. Influenza vaccination is an essential element of preconception, prenata...

September 2014

PDF Format
87.

Informed Consent

Number 439

(Reaffirmed 2012)

ABSTRACT: Obtaining informed consent for medical treatment, for participation in medical research, and for participation in teaching exercises involving students and residents is an ethical requirement that is partially reflected in legal doctrines and requirements. As an ethical doctrine, informe...

August 2009

PDF Format
88.

Innovative Practice: Ethical Guidelines

Number 352

(Reaffirmed 2012)

ABSTRACT: Innovations in medical practice are critical to the advancement of medicine. Good clinicians constantly adapt and modify their clinical approaches in ways they believe will benefit patients. Innovative practice frequently is approached very differently from formal research, which is gove...

December 2006

PDF Format
89.

Institutional Responsibility to Provide Legal Representation

Number 370

(Reaffirmed 2012)

ABSTRACT: Hospitals, academic institutions, professional corporations, and other health care organizations should have policies and procedures by which alleged violations of professional behavior can be reported and investigated. These institutions should adopt policies on legal representation and...

July 2007

PDF Format
90.

Integrating Immunizations Into Practice

Number 558

ABSTRACT: Given demonstrated vaccine efficacy, safety, and the large potential for prevention of many infectious diseases among adults, newborns, and pregnant women, obstetrician–gynecologists should embrace immunizations as an integral part of their women’s health care practice. To provide direct...

April 2013

PDF Format
91.

Intimate Partner Violence

Number 518

ABSTRACT: Intimate partner violence (IPV) is a significant yet preventable public health problem that affects millions of women regardless of age, economic status, race, religion, ethnicity, sexual orientation, or educational background. Individuals who are subjected to IPV may have lifelong conse...

February 2012

PDF Format
92.

Labor Induction or Augmentation and Autism

Number 597

Abstract: Functional oxytocin deficiency and a faulty oxytocin signaling pathway have been observed in conjunction with autism spectrum disorder (ASD). Because exogenous synthetic oxytocin commonly is administered for labor induction and augmentation, some have hypothesized that synthetic oxytocin...

May 2014

PDF Format
93.

Lead Screening During Pregnancy and Lactation

Number 533

ABSTRACT: Prenatal lead exposure has known adverse effects on maternal health and infant outcomes across a wide range of maternal blood lead levels. Adverse effects of lead exposure are being identified at lower levels of exposure than previously recognized in both children and adults. In 2010, th...

August 2012

PDF Format
94.

Magnesium Sulfate Before Anticipated Preterm Birth for Neuroprotection

Number 455

(Reaffirmed 2013)

ABSTRACT: Numerous large clinical studies have evaluated the evidence regarding magnesium sulfate, neuroprotection, and preterm births. The Committee on Obstetric Practice and the Society for Maternal-Fetal Medicine recognize that none of the individual studies found a benefit with regard to their...

March 2010

PDF Format
95.

Magnesium Sulfate Use in Obstetrics

Number 573

ABSTRACT: The U.S. Food and Drug Administration advises against the use of magnesium sulfate injections for more than 5–7 days to stop preterm labor in pregnant women. Based on this, the drug classification was changed from Category A to Category D, and the labeling was changed to include this new...

September 2013

PDF Format
96.

Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women

Number 557

ABSTRACT: Initial evaluation of the patient with acute abnormal uterine bleeding should include a prompt assessment for signs of hypovolemia and potential hemodynamic instability. After initial assessment and stabilization, the etiologies of acute abnormal uterine bleeding should be classified usi...

April 2013

PDF Format
97.

Management of Asymptomatic Pregnant or Lactating Women Exposed to Anthrax

Number 268

ABSTRACT: Anthrax infections are diagnosed by isolating Bacillus anthracis from body fluids or by measuring specific antibodies in the blood of persons suspected to have the disease. It is recommended that asymptomatic pregnant and lactating women who have been exposed to a confirmed environmental...

February 2002

PDF Format
98.

Management of Delivery of a Newborn With Meconium-Stained Amniotic Fluid

Number 379

(Reaffirmed 2013)

ABSTRACT: In accordance with the new guidelines from the American Academy of Pediatrics and the American Heart Association, all infants with meconium-stained amniotic fluid should no longer routinely receive intrapartum suctioning. If meconium is present and the newborn is depressed, the clinician...

September 2007

PDF Format
99.

Management of Pregnant Women With Presumptive Exposure to Listeria monocytogenes

Number 614

ABSTRACT: Listeriosis is predominantly a foodborne illness, with sporadic and outbreak-related cases tied to consumption of food contaminated with listeria (Listeria monocytogenes). The incidence of listeriosis associated with pregnancy is approximately 13 times higher than in the general populati...

December 2014

PDF Format
100.

Management of Vulvar Intraepithelial Neoplasia

Number 509

(Reaffirmed 2014)

ABSTRACT: Vulvar intraepithelial neoplasia (VIN) is an increasingly common problem, particularly among women in their 40s. The term VIN is used to denote high-grade squamous lesions and is subdivided into usual-type VIN (including warty, basaloid, and mixed VIN) and differentiated VIN. Usual-type ...

November 2011

PDF Format